JP2019206562A5 - - Google Patents

Download PDF

Info

Publication number
JP2019206562A5
JP2019206562A5 JP2019140640A JP2019140640A JP2019206562A5 JP 2019206562 A5 JP2019206562 A5 JP 2019206562A5 JP 2019140640 A JP2019140640 A JP 2019140640A JP 2019140640 A JP2019140640 A JP 2019140640A JP 2019206562 A5 JP2019206562 A5 JP 2019206562A5
Authority
JP
Japan
Prior art keywords
configuration
kidney disease
chronic kidney
ferric citrate
patient
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019140640A
Other languages
English (en)
Japanese (ja)
Other versions
JP6828100B2 (ja
JP2019206562A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2019206562A publication Critical patent/JP2019206562A/ja
Publication of JP2019206562A5 publication Critical patent/JP2019206562A5/ja
Application granted granted Critical
Publication of JP6828100B2 publication Critical patent/JP6828100B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019140640A 2013-11-04 2019-07-31 慢性腎臓病患者の心不全を軽減するためのクエン酸第二鉄 Active JP6828100B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361899866P 2013-11-04 2013-11-04
US61/899,866 2013-11-04

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2016552432A Division JP2016535780A (ja) 2013-11-04 2014-11-03 慢性腎臓病患者の心不全を軽減するためのクエン酸第二鉄

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2021007091A Division JP2021073230A (ja) 2013-11-04 2021-01-20 慢性腎臓病患者の心不全を軽減するためのクエン酸第二鉄

Publications (3)

Publication Number Publication Date
JP2019206562A JP2019206562A (ja) 2019-12-05
JP2019206562A5 true JP2019206562A5 (https=) 2020-01-23
JP6828100B2 JP6828100B2 (ja) 2021-02-10

Family

ID=53005244

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2016552432A Pending JP2016535780A (ja) 2013-11-04 2014-11-03 慢性腎臓病患者の心不全を軽減するためのクエン酸第二鉄
JP2019140640A Active JP6828100B2 (ja) 2013-11-04 2019-07-31 慢性腎臓病患者の心不全を軽減するためのクエン酸第二鉄
JP2021007091A Pending JP2021073230A (ja) 2013-11-04 2021-01-20 慢性腎臓病患者の心不全を軽減するためのクエン酸第二鉄

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2016552432A Pending JP2016535780A (ja) 2013-11-04 2014-11-03 慢性腎臓病患者の心不全を軽減するためのクエン酸第二鉄

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2021007091A Pending JP2021073230A (ja) 2013-11-04 2021-01-20 慢性腎臓病患者の心不全を軽減するためのクエン酸第二鉄

Country Status (15)

Country Link
US (3) US20160256486A1 (https=)
EP (2) EP3747432A1 (https=)
JP (3) JP2016535780A (https=)
KR (1) KR102392441B1 (https=)
CN (1) CN105873583A (https=)
AU (1) AU2014341975A1 (https=)
BR (1) BR112016009901A8 (https=)
CA (1) CA2928200A1 (https=)
EA (1) EA201690926A1 (https=)
HK (1) HK1223031A1 (https=)
IL (1) IL245317A0 (https=)
MX (1) MX2016005734A (https=)
SG (1) SG11201603091QA (https=)
TW (2) TW202203910A (https=)
WO (1) WO2015066593A1 (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108938585A (zh) 2009-07-21 2018-12-07 凯克斯生物制药公司 柠檬酸铁剂型
SI3287133T1 (sl) 2013-06-05 2019-09-30 Tricida Inc. Polimeri, ki vežejo protone,za peroralno dajanje
EP3157516A4 (en) 2014-06-22 2017-12-13 Dexcel Pharma Technologies Ltd. Pharmaceutical compositions comprising ferric citrate and methods for the production thereof
LT3229816T (lt) 2014-12-10 2020-05-25 Tricida Inc. Protoną prijungiantys polimerai, skirti peroraliniam įvedimui
WO2017193024A1 (en) 2016-05-06 2017-11-09 Tricida, Inc. Hcl-binding compositions for and method of treating acid-base disorders
IL319146A (en) 2017-11-03 2025-04-01 Tricida Inc Compositions for and method of treating acid-base disorders
JP2022505697A (ja) 2018-10-29 2022-01-14 ファーマコスモス ホールディング エー/エス カルボキシマルトース第二鉄による鉄欠乏症の治療
EA202191858A1 (ru) * 2019-06-12 2021-11-12 Фармакосмос Холдинг А/С Лечение дефицита железа у субъектов с риском нежелательных явлений со стороны сердечно-сосудистой системы и железо для лечения фибрилляции предсердий
CN117999069A (zh) * 2021-05-27 2024-05-07 凯克斯生物制药公司 柠檬酸铁的儿科调配物

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE351366B (https=) * 1965-06-08 1972-11-27 Teikoku Hormone Mfg Co Ltd
US20050203169A1 (en) * 2001-08-06 2005-09-15 Moskowitz David W. Methods and compositions for treating diseases associated with excesses in ACE
US8093423B2 (en) 2003-02-19 2012-01-10 Globoasia, Llc Pharmaceutical-grade ferric organic compounds, uses thereof and method of making same
TWI335218B (en) 2003-02-19 2011-01-01 Panion & Bf Biotech Inc Ferric organic compounds, uses thereof and methods of making same
NZ566743A (en) 2005-08-18 2010-07-30 Globoasia Llc Pharmaceutical-grade ferric organic compounds, uses thereof and methods of making same
EP3066923B1 (en) * 2006-01-30 2025-11-05 Panion & BF Biotech Inc. Method of treating chronic kidney disease
KR20080094013A (ko) * 2006-01-30 2008-10-22 글로보아시아 엘엘씨 연조직의 석회화 역전, 예방, 지연 또는 안정화 방법
CN108938585A (zh) * 2009-07-21 2018-12-07 凯克斯生物制药公司 柠檬酸铁剂型
EP2590655B1 (en) * 2010-07-07 2015-06-24 Ardelyx, Inc. Compounds and methods for inhibiting phosphate transport
SG11201408521WA (en) * 2012-06-21 2015-01-29 Keryx Biopharmaceuticals Inc Use of ferric citrate in the treatment of chronic kidney disease patients

Similar Documents

Publication Publication Date Title
JP2019206562A5 (https=)
JP2017002083A5 (https=)
JP2011522876A (ja) 永続性心房細動を予防するためのドロネダロン
JPH0649651B2 (ja) 心筋虚血治療用医薬組成物
Kiuchi et al. Long-term use of ipragliflozin improved cardiac sympathetic nerve activity in a patient with heart failure: a case report
Sağ et al. Inappropriate sinus tachycardia-induced cardiomyopathy during pregnancy and successful treatment with ivabradine
CN106176703A (zh) 丹酚酸a在制备预防和/或治疗肺动脉高压中的药物用途
CN105748464A (zh) 一种治疗射血分数保留的心力衰竭的药物组合物及其应用
WO2023005002A1 (zh) 枸橼酸爱地那非在制备预防和或治疗肺动脉高压的药物中的用途
CN101588807B (zh) D-核糖在制备治疗心律失常的药物中的应用
Price et al. A case of subendocardial infarction
Kanlop et al. Granulocyte colony‐stimulating factor stabilizes cardiac electrophysiology and decreases infarct size during cardiac ischaemic/reperfusion in swine
US3329567A (en) Synergistic effect of adenylic nucleotides in digitalis therapy
Aypar et al. Voriconazole‐induced QT interval prolongation and torsades de pointes
Fernández-Ruiz Low-dose colchicine shows promise in chronic coronary disease
Sadeghian et al. Short QT syndrome and idiopathic ventricular tachycardia in a 28-year-old young man: a potential disease-specific link?
Gultekin et al. An unusual form of Naxos disease and its improvement by adjuvant low-dose colchicine therapy
JP6028983B2 (ja) ビダラビンによる心房細動治療
EP3842056B1 (en) Use of ghrp-6 as late cardioprotective and cardiac restoration medicament
Lim Benefit of controlling heart rhythm soon after AF diagnosis
JP2007008845A (ja) 慢性心不全治療および/または予防薬
Biyik et al. Left ventricular steal syndrome caused by multiple plexiform coronary artery fistulae: case report, literature review and treatment
Spath Jr et al. Preservation of cardiac cellular integrity by methylpred-nisolone in acute myocardial ischemia
CN102697796B (zh) 金合欢苷在制备抗心肌缺血药物中的应用
Yalçın et al. Aortic interruption in an adult female